Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Cannabinoids act on various regions in the nervous system to modulate neuronal activity including nociception. Here, we investigated CB1 receptor expression in primary afferent neurons in the dorsal root ganglion (DRG) and the efficacy of a local (intraplantar) application of the selective CB1 agonist, 2-arachidonyl-2-chloroethylamide (ACEA), on inflammatory thermal hyperalgesia. In situ hybridization showed normal CB1 mRNA expression in 28% of DRG neurons. Peripheral inflammation by CFA (complete Freund's adjuvant) significantly increased the ratio of CB1 mRNA-positive neurons to 43%, primarily with increase in NF200-negative C-fiber nociceptors. Furthermore, CB1 and TRPV1 (transient potential receptor vanilloid subtype-1) co-localization was increased from 41% before inflammation to 67% two days after inflammation. Inflammation also increased CB1 immunoreactivity in DRG neurons and in nerve fibers of the hindpaw dermis, indicating increased CB1 transport from the cell body to the peripheral nerve. The intraplantar application of ACEA attenuated CFA-induced thermal hyperalgesia. The antinociceptive properties of ACEA became more prominent at 2 days after inflammation, compared with those in non-inflamed and inflamed animals at 8 h. These results suggest that CB1 expression in primary afferent neurons is increased by inflammation and that the subsequent increase in CB1 transport to peripheral axons contributes to the increased antihyperalgesic efficacy of locally administered CB1 agonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ethical guidelines for investigations of experimental pain in conscious animals.
Zimmermann, M. (1983) · Pain · doi:10.1016/0304-3959(83)90201-4 · Cited by 7,762 · cited 3×
“CB1 is expressed throughout the brain 0304-3959/$32.00 2006 International Association for the Study of Pain.”
MethodInfluentialMolecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 2×
“(Mailleux and Vanderhaeghen, 1992) whereas CB2 is located primarily on immune cells (Munro et al., 1993).”
BackgroundStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · cited 1×
“Two distinct cannabinoid receptors, CB1 and CB2, have since been characterized (Matsuda et al., 1990; Munro et al., 1993).”
BackgroundImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586 · cited 2×
“CB1 is expressed in areas that are involved in pain modulation including periaqueductal gray (Tsou et al., 1998) and the dorsal horn of the spinal cord (Farquhar-Smith et al., 2000).”
BackgroundCannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
Twitchell, W., Brown, S., & Mackie, K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.1.43 · Cited by 544 · cited 2×
“, 1995), decreases calcium conductance (Caulfield and Brown, 1992; Twitchell et al., 1997) and modulates potassium channels (Deadwyler et al.”
BackgroundIbrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521
CB2 cannabinoid receptor-mediated peripheral antinociception
Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain · doi:10.1016/s0304-3959(01)00321-9 · Cited by 391
Hohmann, A. G., & Herkenham, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00524-7 · Cited by 301
Cannabinoid CB1 Receptor Expression in Rat Spinal Cord
Farquhar-Smith, W. P., Egertová, M., Bradbury, E. J., McMahon, S. B., Rice, A. S. C., & Elphick, M. R. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0844 · Cited by 268 · cited 2×
“CB1 is expressed in areas that are involved in pain modulation including periaqueductal gray (Tsou et al., 1998) and the dorsal horn of the spinal cord (Farquhar-Smith et al., 2000).”
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…Drew et al., 2000; Naderi et al., 2005; Suplita et al., 2006), and peripheral sensory nerves (Calignano et al., 1998; Richardson et al., 1998c; Hohmann and Herkenham, 1999; Fox et al., 2001; Johanek et al., 2001; Kelly et al., 2003; Johanek and Simone, 2004; Jordt et al., 2004; Amaya et al., 2006).”
BackgroundPertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
SVIZENSKA, I., DUBOVY, P., & SULCOVA, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.05.010 · Cited by 457
Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290
The Role of the Endocannabinoid System in the Brain–Gut Axis
Sharkey, K. A., & Wiley, J. W. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.015 · Cited by 253
Peripheral gating of pain signals by endogenous lipid mediators
Piomelli, D., & Sasso, O. (2014) · Nature Neuroscience · doi:10.1038/nn.3612 · Cited by 246
“For example, prolonged peripheral inflammation elicited by injection of complete Freund’s adjuvant (CFA) in the rat hind paw, is accompanied by elevation of CB 1 receptor density in dermal nerve endings and cell bodies of nociceptive neurons that project to that paw 23 .”
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S.-J., & Mackie, K. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 174
“While the possible reasons for these discrepancies have been well discussed elsewhere (Marsicano and Kuner 2008), it is also important to note that the expression and peripheral transport of CB1 receptors in the DRG can be upregulated by peripheral inflammation (Amaya et al. 2006).”
BackgroundSchuelert, N., Johnson, M. P., Oskins, J. L., Jassal, K., Chambers, M. G., & McDougall, J. J. (2011) · Pain · doi:10.1016/j.pain.2010.11.025 · Cited by 70
“Controversially, it has been reported that local AM251 application caused hyperalgesia in control rats but not acutely inflamed animals [1], suggesting a depression of endocannabinoid tone during inflammation.”
BackgroundAuh, Q.-S., Chun, Y. H., Melemedjian, O. K., Zhang, Y., & Ro, J. Y. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.07.009 · Cited by 14
Metadata
- Authors
- Amaya, F., Shimosato, G., Kawasaki, Y., Hashimoto, S., Tanaka, Y., Ji, R.-R., & Tanaka, M.
- Venue
- Pain
- Published
- 2006-09
- Volume
- 124
- Issue
- 1
- Pages
- 175-183
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2046586945
- Cited by
- 120
- References
- 12
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.